{
    "code": 0,
    "data": [
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "news_id": "c486237a-dda3-4ec9-995a-a99d41a31bac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f72e6c77-575d-4666-9bcd-68fd3384a1f0.pdf",
            "news_date": "2026-02-10 17:48:44",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q3 FY26 Earnings Call held on February 06 2026.",
            "news_id": "8f7f1999-d117-4abc-aeec-946f8b9bd1dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3179c58-96eb-4700-8713-d07a88d2d286.pdf",
            "news_date": "2026-02-06 18:47:37",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2025 along with the Limited Review Report for the said period.",
            "news_id": "6db61019-0809-4488-b17b-0631f8f0f14c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8471c1c-a0c5-469e-accb-2c46c61d4525.pdf",
            "news_date": "2026-02-06 13:47:07",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Earnings Call Transcript pertaining to unaudited financial results of the company for the quarter and half year ended September 30 2025",
            "news_id": "0b6b15c4-4df3-4589-8793-029ea0e032f8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c80c36b5-5724-46ea-af3b-9b63582e165c.pdf",
            "news_date": "2025-11-11 14:53:37",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q2 FY26 Earnings Call held on November 05 2025.",
            "news_id": "5c08553e-7e19-4362-9678-1114df43c82a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3182cfc8-2dd2-4cd9-a844-184da8356c46.pdf",
            "news_date": "2025-11-05 18:25:50",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Exchange regarding the Inter alia to consider and approve the Unaudited Financial Statements for the quarter and half year ended September 30 2025 alongwith the Limited Review Report for the said period.",
            "news_id": "3e5d66cf-2767-4e6e-8907-4f364f729420",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07404f29-b83c-4023-9443-8fc587da8249.pdf",
            "news_date": "2025-11-05 14:17:05",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors conference call held on Friday July 25 2025.",
            "news_id": "7f1a498a-c178-4311-9a09-2fb864d8fe0e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd708187-046a-445e-a17f-c806a729cbdf.pdf",
            "news_date": "2025-07-29 16:05:36",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2025 along with the Limited Review Report for the said period.",
            "news_id": "bd9762a2-d030-4c7b-9f48-76402b1ab1e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=642420f6-0d93-4c62-aa5b-94cee1b14b7a.pdf",
            "news_date": "2025-07-25 13:23:48",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Solara Active Pharma Sciences Limited has informed the Stock Exchange regarding the Earnings Call Transcript for the Analysts/Investors Conference Call held on May 15 2025.",
            "news_id": "a5c08d85-75d8-41ec-917f-cf9361b9b6c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdab947e-35c8-4ae3-aec9-7835df11c109.pdf",
            "news_date": "2025-05-21 15:53:03",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Solara Active Pharma Sciences Limited has informed the exchange regarding inter alia the Audited standalone and Consolidated Financial Results for the quarter and year ended March 31 2025 along with Auditors report for the said period",
            "news_id": "1112947a-3f13-45da-9975-3b3664efc16f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b81dc1d2-682c-4b4c-8469-98126acb450e.pdf",
            "news_date": "2025-05-15 14:24:08",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Board Meeting held on January 24 2025.",
            "news_id": "57350834-8043-401b-bfaa-be048f28415a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5a859f1-1315-4a91-b0dd-9dc13be940f6.pdf",
            "news_date": "2025-01-31 14:57:07",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Board Meeting Held today interalia to consider and approve the unaudited financial results for the quarter ended December 31 2024 and other matters.",
            "news_id": "bf17eecf-e153-43e6-b025-d77f2fec053d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f78ede-dc89-44c8-b4a2-d7ecc8a379bf.pdf",
            "news_date": "2025-01-24 14:46:27",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the Board Meeting held on October 21, 2024",
            "news_id": "4a9a3f82-066f-45c6-b681-93b86826b9d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b29a992d-d676-4e46-a1e4-d1623da7cd2f.pdf",
            "news_date": "2024-10-28 11:34:24",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con Call Audio Recording",
            "news_id": "c2c3c45e-ef63-422a-859e-6b9eaf8722b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41e806b6-1e0a-4f1f-bb94-5789ac2d4bb6.pdf",
            "news_date": "2024-10-21 19:17:57",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Solara Active pharma Sciences Limited has informed the Exchange regarding Board meeting held on October 21, 2024 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2024 and allotment of 49,000 equity shares pursuant to exercise of ESOP granted under SOLARA ESOP Plan 2018",
            "news_id": "e4d4b103-6462-4ed3-a1ee-9e2cbcffc85c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af90b8a4-b506-40d0-b910-0c45407e4c37.pdf",
            "news_date": "2024-10-21 14:29:02",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for the con-call held on July 22, 2024",
            "news_id": "0e19026b-ef5f-405a-9f14-f07b41730a65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ea196c2-01af-416f-aa85-aec959bae507.pdf",
            "news_date": "2024-07-26 20:13:37",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con Call Audio Recording",
            "news_id": "863dbb2e-0c7f-471e-8b12-261026a9518a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aad8b0a7-e412-4454-8363-1ad5e184be3d.pdf",
            "news_date": "2024-07-22 17:28:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited financial results for the quarter ended June 30, 2024",
            "news_id": "552636e2-6c1e-4d1d-93b6-2a18528a98ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc7b7e11-3628-4a24-b267-9c82aded4f0e.pdf",
            "news_date": "2024-07-22 14:04:50",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited financial results for the quarter ended June 30, 2024",
            "news_id": "d20634e1-cb43-421d-a6d4-17c782e58197",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7310d508-be51-4fc7-9413-2425c6822806.pdf",
            "news_date": "2024-07-22 14:02:19",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings conference call held for the quarter ended March 31, 2024",
            "news_id": "673ccf8e-9f10-43a3-88df-a7b54cf54fdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5271c7c0-9763-407d-bb53-ddc965891340.pdf",
            "news_date": "2024-06-04 11:53:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con-call Audio recording for the Investor call held on May 29, 2024.",
            "news_id": "ab565791-c291-4377-9fe7-1890bcd79297",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554bed00-d888-4035-a012-557700f22602.pdf",
            "news_date": "2024-05-29 17:36:23",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Period Ended March 31, 2024",
            "news_body": "Results for the period ended March 31, 2024",
            "news_id": "623b54fd-5418-4ba5-a9d8-625d35808dae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8112e42a-0564-403e-b8df-5dfcd8c3a0cd.pdf",
            "news_date": "2024-05-29 15:36:23",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the earnings conference call for the quarter ended December 31, 2023.",
            "news_id": "8ebc48c5-9edc-44b8-bfa2-4388e7e5e70b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25957af6-ed81-4e1b-9198-841881e86c50.pdf",
            "news_date": "2024-02-21 10:36:39",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Con-call audio recording held to discuss Q3 FY24 Unaudited Financial Results.",
            "news_id": "1e0143eb-44f3-4cd9-838e-0ca8887887ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1a5b4f7-4d77-49c9-9fc4-33f5d4df690a.pdf",
            "news_date": "2024-02-14 18:49:58",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended December 31, 2023.",
            "news_body": "Unaudited Financial Results for the period ended December 31, 2023",
            "news_id": "bd7be511-0ac5-42c6-ae7b-f599c2947dfa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feb3922a-2794-425b-ae95-2b25fa62fa7f.pdf",
            "news_date": "2024-02-14 14:03:27",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call Transcript of the call held on November 14, 2023",
            "news_id": "2acb9ac2-3619-42f5-ab35-1236ebe60a7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b75ef5e-68ef-4eed-b743-ff697809dcf7.pdf",
            "news_date": "2023-11-20 20:11:39",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (LODR), we hereby confirm that we have uploaded audio recording of the Q2 of FY24 earnings call held on November 14, 2023, on our company website.",
            "news_id": "6044678c-8098-46c7-8005-13d6a181e254",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea4bbc9e-f695-4dce-bc8a-2389d1d8c9f4.pdf",
            "news_date": "2023-11-14 18:07:47",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended September 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended September 30, 2023",
            "news_id": "79cff787-0207-4774-895b-4955d0bb81b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c7b7ca-fca3-4aed-8856-32576711b1f2.pdf",
            "news_date": "2023-11-14 15:03:58",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (LODR), please find enclosed the transcript of the earnings conference call for the quarter ended June 30, 2023, conducted after the meeting of Board of Directors held on August 14, 2023, for your information and records.",
            "news_id": "d2d0b39f-387e-442b-bc1d-a6eeb8d8b5d2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e2d10ec-499b-4ae8-be64-bce0671e9a4f.pdf",
            "news_date": "2023-08-21 14:22:43",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 of SEBI (LODR) we wish to inform that we have uploaded audio recording of the Q1 of FY24 earnings call held on August 14, 2023, on our company website.",
            "news_id": "0cef4f19-ad08-435a-a011-54b8d80f5332",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d8a2ef3-2829-4680-bebf-b1b45f532b36.pdf",
            "news_date": "2023-08-14 17:04:45",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2023 along with limited review report and press release is attached.",
            "news_id": "3cdb5ee3-c1b6-4c84-8256-9a7b8fdecd10",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=837a4a4c-bff6-4114-a1f9-a94be52960fb.pdf",
            "news_date": "2023-08-14 14:00:39",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended March 31, 2023, conducted after the meeting of Board of Directors held on May 12, 2023, for your information and records.",
            "news_id": "42bd6fb5-b47c-4160-925a-1a56d73efc9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0996d757-2036-48b8-ba9b-d8a26cdf0c3c.pdf",
            "news_date": "2023-05-18 19:09:57",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q4 of FY23 Earnings Call held on May 12, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.",
            "news_id": "5e5c9f8f-7abb-4260-9824-0151fdfa5200",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ace3ff6-d2dd-4baf-8105-4946a3ffeb2d.pdf",
            "news_date": "2023-05-12 18:42:52",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited financial results (standalone and consolidated) of the Company for the quarter and Year ended March 31, 2023, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. A copy of the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2023, along with the Auditors report for the said period and press release on the same is attached.",
            "news_id": "fe24ab47-5f42-488e-b7ba-3240e4657be6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62bc3310-db79-4a9a-b98f-d8cfa21cbd6d.pdf",
            "news_date": "2023-05-12 14:32:02",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclose the transcript of the earnings conference call for the quarter ended December 31, 2022, conducted after the meeting of Board of Directors held on January 25, 2023, for your information and records.",
            "news_id": "142f299c-cf2c-459e-8dd6-75af250dde05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f869ef58-2b4c-4813-9612-43ae3e927fb8.pdf",
            "news_date": "2023-02-01 13:23:17",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q3 of FY23 Earnings Call held on January 25, 2023, on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.",
            "news_id": "1a0be46f-1762-4e8a-a5d3-b68fc850f411",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8283aab4-3ba7-4262-918a-f6abcaa00d94.pdf",
            "news_date": "2023-01-25 18:36:53",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 25, 2023",
            "news_body": "Outcome of Board Meeting held on January 25, 2023",
            "news_id": "4830a3cc-5c1f-48f0-8d47-74934e531c98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dafb3b8-a939-4cc9-b90f-25c6b9857c3b.pdf",
            "news_date": "2023-01-25 14:16:48",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended December 31, 2022.",
            "news_body": "Unaudited financial results (standalone and consolidated) of the Company for the quarter ended December 31, 2022. A copy of the unaudited financial results (standalone andconsolidated) for the quarter ended December 31, 2022, along with the Limited Review Report by the Auditors and press release is attached.",
            "news_id": "bcd3802a-e62a-40c3-911f-562fe92d472f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9227091f-ea5f-43ac-9c25-298924893330.pdf",
            "news_date": "2023-01-25 13:56:45",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions For The Half Year Ended September 30, 2022",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, we hereby enclose disclosure on Related Party Transactions, for the half year ended September 30, 2022.",
            "news_id": "aae6cb69-d7c1-41cf-8cf2-6f7131b4e137",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71d5beb0-8bdc-4e53-acea-a2e6166da4a4.pdf",
            "news_date": "2022-11-21 17:23:26",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter ended September 30, 2022, conducted after the meeting of Board of Directors held on November 9, 2022",
            "news_id": "5c65376c-9679-457d-b923-e1d1c1036f3c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0933b48-babc-4e7b-83a2-aeeb447275e3.pdf",
            "news_date": "2022-11-15 14:52:05",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that we have uploaded audio recording of the Q2 of FY23 Earnings Call held on November 9, 2022, on our Company website",
            "news_id": "ef9ae282-3995-4724-84c4-859771976e2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aec98359-96f8-40f3-80e0-526019e46638.pdf",
            "news_date": "2022-11-09 18:38:25",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended September 30, 2022",
            "news_body": "We wish to inform that meeting of Board of Directors of the company held today (i.e., November 9, 2022), the Directors has inter-alia approved Unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure<BR> Requirements) Regulation, 2015. A copy of the unaudited financial results (standalone and consolidated) along with the Limited Review Report by the Auditors and press release is attached.",
            "news_id": "4b37592e-128f-4188-be9b-713cc8519d15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1462de29-e37a-4e27-8869-82dc71cfb34c.pdf",
            "news_date": "2022-11-09 13:31:42",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the Earnings Call held on August 4, 2022.",
            "news_id": "a2cc9693-0bb3-4a8f-991e-2ec78af127e6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77ec6862-2ae3-4d11-87a4-47344f55c38e.pdf",
            "news_date": "2022-08-10 13:10:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022 Along With Limited Review Report And Press Release.",
            "news_body": "Unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2022, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. A copy of the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2022, along with the Limited Review Report<BR> by the Auditors and press release is attached.",
            "news_id": "c849a338-5e06-43e5-afb8-c49b7c56460a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=786e9c06-a2c4-45d3-ae98-382be4cf2517.pdf",
            "news_date": "2022-08-04 13:50:49",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Period Ended March 31, 2022",
            "news_body": "Disclosure Of Related Party Transactions For The period Ended March 31, 2022",
            "news_id": "18ddb620-2c5f-4d1c-b7f9-9ad8ed23ac65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5995e23-1da1-4007-8d69-e37ce3ef52e1.pdf",
            "news_date": "2022-05-13 13:17:51",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and year ended March 31, 2022, conducted after the meeting of Board of Directors held on April 29, 2022, for your information and records.",
            "news_id": "fac6e86c-5219-4fae-ad4a-7d785911b1d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6653f98-4599-4eeb-ac08-fa90a4604dd5.pdf",
            "news_date": "2022-05-06 13:58:02",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached updated Investor Presentation and request you to take the same on record.",
            "news_id": "62bf1ad0-238a-4943-9dc5-21445d2fda75",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=482d92d7-1b2d-4f9e-816f-9977b5325375.pdf",
            "news_date": "2022-05-02 11:55:12",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirmthat we have uploaded audio recording of the Q4 of FY22 Earnings Call held on April 29, 2022, on our Company website",
            "news_id": "a5b68f31-08c0-484c-b165-7dd9ea9ee5c8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6849150e-8805-40bc-838a-3df179644841.pdf",
            "news_date": "2022-04-30 11:05:20",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Andyear Ended March 31, 2022 Pursuant To Regulation 33 Of SEBI (Listing Obligations Anddisclosure Requirements) Regulation, 2015. A Copy Of The Audited Financial Results(Standalone And Consolidated) For The Quarter And Year Ended March 31, 2022 Along With<BR> The Auditors Report For The Said Period And Press Release On The Same Is Attached",
            "news_body": "Audited financial results (standalone and consolidated) of the Company for the quarter andYear ended March 31, 2022 pursuant to Regulation 33 of SEBI (Listing Obligations andDisclosure Requirements) Regulation, 2015. A copy of the audited financial results(standalone and consolidated) for the quarter and year ended March 31, 2022 along with<BR> the Auditors report for the said period and press release on the same is attached",
            "news_id": "af16356d-dd17-4834-9d7e-f69e7066af2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16f4defd-391b-4b70-8e26-9e7be479cb56.pdf",
            "news_date": "2022-04-29 15:06:16",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Financial results for the period ended december 31st, 2021",
            "news_id": "000297d3-96de-4eae-93c0-5122e8dabcf5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80d0bd27-ec8a-40f8-bdf8-dc03994d86be.pdf",
            "news_date": "2022-02-09 16:07:32",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter And Half Year Ended September 30, 2021.",
            "news_body": "We wish to inform that meeting of Board of Directors of Solara Active Pharma Sciences Limited ('Company') held today (i.e., November 11, 2021), the Directors has inter-alia approved Unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2021 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.<BR>",
            "news_id": "fd9bd78e-2da3-4b9f-946a-7b7cc7ce11e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6b2f7f6-6ec7-41e4-9563-93fdf02bbf62.pdf",
            "news_date": "2021-11-11 14:42:31",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Update - Intimation of Analysts / Institutional Investors Conference Call.<BR> <BR> Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Thursday, November 11, 2021, to discuss its Q2 financial results.",
            "news_id": "dc4cbeca-3505-467b-ac73-c54cc7797a84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cc3f300-b79a-486c-8718-f1c3dfbd3b6c.pdf",
            "news_date": "2021-11-09 13:27:45",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Thursday, November 11, 2021, to discuss its Q2 financial results.",
            "news_id": "826f0e79-1eba-47a8-9c47-1c5daaa25a34",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f95e76c-a792-4839-a062-c4a041ca6ca6.pdf",
            "news_date": "2021-11-08 16:13:33",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "Please refer our letter dated July 28, 2021 under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, in continuation we wish to inform that at the meeting of Board of Directors held today (August 4, 2021) the Directors has inter-alia approved Unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2021.",
            "news_id": "f17dd423-5276-4e9d-98cc-a72b608ee4b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=153e336e-fb60-4be5-b4c4-270a36349be0.pdf",
            "news_date": "2021-08-04 14:16:01",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Wednesday, August 4, 2021 to discuss its Q1 financial results.",
            "news_id": "c734172a-e995-4fc6-9f71-0e8a657fd9e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=497a94be-eb48-46c6-8010-ed168e82f94f.pdf",
            "news_date": "2021-07-28 12:09:43",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Year Ended March 31, 2021",
            "news_body": "Disclosure of Related party transactions for the year ended March 31, 2021",
            "news_id": "44520acf-e307-4a85-b00a-57e24886d137",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=142275a3-8146-41a2-94d9-67b9d647eb7e.pdf",
            "news_date": "2021-06-03 13:58:52",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company will be participating in the virtual investor conference on May 25, 2021, organised by Spark capital.",
            "news_id": "bb4f9b38-c8cd-4e19-b7e9-7d398282e053",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2632d123-0d07-4615-87cb-231e07b011cd.pdf",
            "news_date": "2021-05-24 13:54:35",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "The Company will be participating in the virtual annual investor conference today i.e May 19, 2021, organised by DAM Capital Advisors limited.",
            "news_id": "cb00c3ff-3d54-4dcd-b43a-ea62e1d5ea2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08059b4e-4e90-4672-ab0f-cc93bb06d094.pdf",
            "news_date": "2021-05-19 10:49:32",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For March 31, 2021.",
            "news_body": "Results - Financial Results for March 31, 2021.",
            "news_id": "372b0f34-192f-4737-b5c6-39fff6942a9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc8d7ec3-dea7-4bb1-81fd-7a08aa0c86ed.pdf",
            "news_date": "2021-05-06 15:13:44",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the Investors / Analysts on Thursday 6th May 2021, 3:30 pm IST to discuss on Q4 results.",
            "news_id": "60cab3a8-fb9f-4156-980f-559f8b481650",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7f1b33b-55e2-4aaf-924c-9393fd0a7cd5.pdf",
            "news_date": "2021-04-30 17:11:27",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached Investor presentation issued by the Company titled:<BR> 'ACCELERATING GROWTH: SOLARA AND AURORE MERGE TO BECOME INDIA'S SECOND LARGEST PURE PLAY API / CRAMS COMPANY'",
            "news_id": "7179bd15-ff1a-40e2-8269-c08fa3aec289",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc4b8d50-2534-4280-b790-322869dd102d.pdf",
            "news_date": "2021-04-11 17:01:19",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "UPDATE - conference call with the Investors / Analysts on Monday 12th April 2021, 9:00 am IST -  with updated link for the call.",
            "news_id": "53d3ca71-8f10-4c05-9edc-cd77e515c90b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05f9761c-956b-497f-93b2-4120457e9a6f.pdf",
            "news_date": "2021-04-09 20:48:13",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SOLARA",
            "disp": "Solara Active Pharma Sciences",
            "bse_code": 541540,
            "isin": "INE624Z01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the Investors / Analysts on Monday 12th April 2021, 9:00 am IST.",
            "news_id": "af28ac67-ff95-4968-8a8b-75023a1679de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=838bc498-80e4-429c-a274-54d73bd5b6d6.pdf",
            "news_date": "2021-04-09 19:39:50",
            "seo": "solara-active-pharma-sciences-ltd",
            "ltp": 487.9,
            "ch": -2.3500000000000227,
            "pch": -0.47934727180010667,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 3672,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}